How long before surgery should you stop taking Mounjaro?

Mounjaro slows the movement of food through the stomach (gastric emptying), which persists even after a dose, this is the clinical basis for the pre-surgery guidance.
NHS England recommends stopping GLP-1 and dual-agonist medicines before surgery and informing the anaesthetist; the minimum interval commonly cited is one week before an elective procedure.
Even on an empty stomach, residual gastric slowing from tirzepatide may mean food remains present longer than usual, standard pre-operative fasting alone may not eliminate the risk.
Restarting after surgery depends on your recovery and the nature of the procedure, your prescriber or surgical team decides the right point to resume, not a fixed number of days.

Current NHS guidance recommends stopping Mounjaro (tirzepatide) before any surgical procedure. NHS England advises telling your anaesthetist and the whole surgical team that you take a GLP-1 or dual-agonist medicine — and stopping treatment in advance — because slowed gastric emptying increases the risk of regurgitation and aspiration under anaesthesia. The exact timing should be confirmed by your surgical team, but the standard recommendation cited in NHS guidance is to stop at least one week before an elective procedure. This page sets out what is currently known, where the evidence is still developing, and who needs to make this call for your specific situation. Mounjaro is a prescription-only medicine; any decision about pausing, stopping or restarting it must involve your prescriber or surgical team, not a pharmacine read on your own.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the guidance says, why it matters, and who decides

Why gastric emptying changes the risk calculation for anaesthesia

Tirzepatide works partly by slowing how quickly food leaves the stomach. Under normal circumstances, a standard pre-operative fast of six hours for food and two hours for clear fluids reliably empties the stomach before a general anaesthetic. The concern with GLP-1 and dual GIP/GLP-1 medicines like Mounjaro is that this assumption may not hold: the medicine can keep stomach contents in place longer than expected, even when a patient believes they have fasted correctly.

The consequence of that mismatch is aspiration, inhaling stomach contents into the lungs during intubation or emergence from anaesthesia. This is a well-recognised anaesthetic risk and a serious one. NHS England's guidance on weight-management injections flags it directly, advising patients to tell their healthcare team, including the anaesthetist, before any surgical procedure. The NHS England weight-management injections page is the primary UK reference for this recommendation.

One detail worth noting: the risk is not simply a function of when you last ate. Because tirzepatide's mechanism persists across the week between injections, the residual pharmacological effect on gastric motility can linger even if your stomach feels subjectively empty. That is why the guidance extends beyond fasting advice and into stopping the medicine altogether before elective work.

The one-week interval: what the guidance says and where uncertainty remains

The interval most commonly referenced in NHS and anaesthetic guidance for GLP-1 medicines is stopping at least one week before an elective procedure, effectively skipping one weekly dose of Mounjaro. This is consistent with the medicine's once-weekly dosing schedule and provides a reasonable washout period for the gastric-emptying effect to diminish, though it does not mean the medicine is fully cleared from the body within seven days.

For a fuller picture of timing considerations across different situations, the how long to stop Mounjaro before surgery page covers the range of scenarios in more depth. What is less settled is what to do before emergency procedures, before procedures under regional rather than general anaesthesia, or in patients at higher surgical risk for other reasons. The honest answer is that the evidence base here is still developing. Societies representing anaesthetists in the UK and internationally have published their own interim guidance, which your surgical team will be working from, and it may differ in detail from a general NHS patient information page.

If you are uncertain, the right step is to contact your surgical team directly and name the medicine and your current dose. Do not assume the pre-operative questionnaire covered it. A question our prescribers hear regularly is whether patients should just quietly pause and say nothing; they should not, the anaesthetic plan may need to change, and your team needs to know.

Restarting Mounjaro after surgery: the part that often goes unasked

Pausing a weight-loss medicine before surgery is only half the picture. When to restart matters too, and it is genuinely individual. After abdominal surgery, gastrointestinal function may take time to normalise; reintroducing a medicine that further slows gastric emptying before the gut has recovered could worsen nausea, vomiting or ileus. For procedures with no GI involvement the calculus is different again.

There is no fixed number of days after which restart is automatically appropriate. Your prescriber and surgical team decide based on the type of procedure, your recovery trajectory and any complications. If you are a nume patient and your surgery is planned, the right time to flag it is before you stop, raise it during a consultation or via aftercare, so your prescriber can note it and help coordinate the restart plan. You can reach the team through our contact page any day of the week.

For broader context on how long people typically continue Mounjaro as a treatment and what happens when they pause, the how long you should use Mounjaro page sets out the general picture. And if this situation has you thinking about how the medicine works over time, how long Mounjaro takes to work covers the week-by-week trajectory in clinical terms.

What to do now if surgery is coming up

If a procedure is already scheduled, work backwards from the date: contact your surgical team to confirm their required interval, then tell your Mounjaro prescriber so they can document the pause and avoid a repeat dispatch landing while you are mid-stop. Do not simply skip doses without telling anyone, a gap in treatment combined with a significant change in circumstances is exactly the kind of thing a prescriber needs to know about.

We know it can feel unsettling to pause treatment when things are going well. That frustration is entirely reasonable. If surgery has prompted you to reconsider your treatment plan more broadly, it is worth reading about when you should stop taking Mounjaro, which covers the clinical reasons a prescriber might recommend ending treatment, not just pausing it. The pause is temporary; the clinical review around restarting protects the continuity of your progress.

Mounjaro is licensed in the UK for weight management in adults with a qualifying BMI, and the Mounjaro overview page covers the full picture of how it works, eligibility and what private treatment involves. If you are not yet on treatment and are considering it ahead of (or after) a planned procedure, starting a free consultation is the first step; a GPhC-registered prescriber reviews your answers the same day and can take your surgical timeline into account, including questions about how long you should take Mounjaro given your circumstances, from the outset.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions